Are you Dr. Gruber?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 21 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4511 Rancho Del Mar Trl
San Diego, CA 92130Phone+1 858-775-8348- Is this information wrong?
Summary
- Dr. Harry Gruber, MD is a rheumatologist in San Diego, California. He is currently licensed to practice medicine in California.
Education & Training
- Perelman School of Medicine at the University of PennsylvaniaClass of 1977
Certifications & Licensure
- CA State Medical License 1978 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 9 citationsPD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models.Leah Mitchell, Kader Yagiz, Andrew Hofacre, Sophie Viaud, Anthony W. Munday, Fernando Lopez Espinoza, Daniel Mendoza, Maria Rodriguez-Aguirre, Simon Bergqvist, Ali Hag...> ;Oncotarget. 2019 Mar 19
- 21 citationsA Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer ModelsKader Yagiz, Maria Rodriguez-Aguirre, Fernando Lopez Espinoza, Tiffany T. Montellano, Daniel Mendoza, Leah Mitchell, Carlos E. Ibanez, Noriyuki Kasahara, Harry E. Grub...> ;Molecular Therapy Oncolytics. 2018 Mar 30
- 15 citationsToca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma modelsKader Yagiz, Tiffany T. Huang, Fernando Lopez Espinoza, Daniel Mendoza, Carlos E. Ibanez, Harry E. Gruber, Douglas J. Jolly, Joan M. Robbins> ;Neuro-Oncology. 2016 Oct 1
- Join now to see all
Press Mentions
- Caristo Diagnostics Applauds FDA Approval of Colchicine as First Anti-Inflammatory Drug for Cardiovascular DiseaseJune 28th, 2023